Press releases

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 26, 2014-- Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 24, 2014-- Covidien plc (NYSE: COV) will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, Fla., on March 3. Charles J....

MINNEAPOLIS -- February 21, 2014 -- On February 20, 2014, Medtronic, Inc. (NYSE: MDT) registered an offering of $250 million principal amount of its 0.875% Senior Notes due 2017, $250 million...

MINNEAPOLIS - Feb. 20, 2014 - Continuing its leadership in advanced pacing technology and device miniaturization, Medtronic, Inc. (NYSE: MDT), today announced the first U.S. implant of the world's...

MINNEAPOLIS - February 19, 2014 -Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of...

MINNEAPOLIS - Feb. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2014, which ended January 24, 2014. The company reported worldwide...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 18, 2014-- Covidien plc (NYSE: COV) will present at two upcoming investor conferences -- the Citi 2014 Global Healthcare Conference on Feb. 25 and the RBC...

MINNEAPOLIS - Feb 18, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 2014 Citi Global Healthcare Conference on...

(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - February 14, 2014 - Medtronic, Inc. (NYSE: MDT), today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial...

MINNEAPOLIS -- Feb. 13, 2014 -- Aligned with its commitment to provide innovative medical technology for the interventional treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) has...

MINNEAPOLIS - February 13, 2014 - Medtronic, Inc. (NYSE:MDT) has begun distribution of i-port Advance® as part of a continued focus to provide meaningful therapy management solutions for people...

MINNEAPOLIS - February 13, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.28 per share of the Company's common stock. The quarterly dividend...

MINNEAPOLIS - Feb. 11, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2014 on Tuesday, February 18, 2014. A news...

(Thomson Reuters ONE via COMTEX) --Latest Continuous Glucose Monitoring Sensor Provides Improved Comfort and Sensing Experience VIENNA - February 6, 2014 - Medtronic, Inc. (NYSE:MDT) today...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 6, 2014-- Covidien plc. (NYSE:COV) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company’s Endo GIA™...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 4, 2014-- Covidien plc (NYSE: COV) will present at the 2014 Leerink Global Healthcare Conference in New York on Feb. 12. Coleman N. Lannum, vice president,...

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended December 31, 2013, at 8:00 a.m. U.S. Eastern Standard Time...

Dubai, UAE - 28 January 2014, Medtronic, Inc. (NYSE: MDT), the world's largest medical technology company, providing therapies to treat many conditions including cardiac and vascular diseases,...

MINNEAPOLIS -- Jan. 28, 2014 -- Continuing to expand the role of endovascular aortic repair, Medtronic, Inc. (NYSE: MDT) has received approval from the U.S. Food and Drug Administration (FDA) for...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that Charles J. Dockendorff, executive vice president and chief financial officer, has decided to retire...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 24, 2014-- Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of

MUMBAI, India--(BUSINESS WIRE)--Jan. 23, 2014-- Further developing its capabilities in a key emerging market, Covidien (NYSE:COV) has officially opened its first training and education center in...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 23, 2014-- Covidien plc. (NYSE: COV) does not infringe certain patents held by Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, according to a...

BOULDER, Colo.--(BUSINESS WIRE)--Jan. 22, 2014-- Expanding its industry-leading vessel and tissue sealing portfolio, Covidien (NYSE:COV) received U.S. Food and Drug Administration (FDA) 510(k)...

MINNEAPOLIS - January 22, 2014 - Medtronic, Inc. (NYSE: MDT), today announced that the Medtronic SureScan® pacing systems - the first and only pacing systems in the United States that have been...

MINNEAPOLIS - Jan. 22, 2014 - Medtronic, Inc. (NYSE: MDT) announced that the U.S. Supreme Court ruled 9-0 in favor of Medtronic that the burden of proving infringement rests with the party...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 21, 2014-- Covidien plc (NYSE: COV) today announced it will exit its OneShot™ Renal Denervation program. This voluntary action is primarily in response to...

MINNEAPOLIS - Jan. 17, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve® System for severe...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 16, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

MINNEAPOLIS - Jan. 15, 2014 - A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic (NYSE:MDT) CoreValve® System infringed on...

DUBLIN--(BUSINESS WIRE)--Jan. 15, 2014-- Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 13, 2014-- Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one...

MINNEAPOLIS - January 9, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that its U.S. pivotal trial in renal denervation for treatment-resistant hypertension, SYMPLICITY HTN-3, failed to meet...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 9, 2014-- Covidien plc (NYSE: COV), Lightstone Ventures and New Enterprise Associates (NEA) will jointly invest in a new company launched by The Foundry, a...

MINNEAPOLIS - Jan 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual J.P. Morgan Healthcare Conference on...

MINNEAPOLIS - Jan. 6, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first patient has been enrolled in the VICTORY AF clinical trial, a prospective, non-randomized, controlled study of...

MINNEAPOLIS - Jan. 06, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired TYRX, Inc., a privately held, New Jersey-based developer of implantable combination antibiotic drug...

Thomson Reuters ONE via COMTEX) --Medtronic's Second Randomized, Controlled Renal Denervation Clinical Trial in the U.S. Will Potentially Expand Access to the Symplicity(TM) Renal Denervation...

Thomson Reuters ONE via COMTEX) --Medtronic Initiates Global Clinical Trial for Miniature Transcatheter Pacemaker System MINNEAPOLIS - December 9, 2013 - Continuing its leadership in advanced...

Thomson Reuters ONE via COMTEX) --Study Shows Prestige® Cervical Disc Replacement Maintained Clinical Improvements, Lower Rate of Additional Surgical Procedures Compared to ACDF MEMPHIS, TENN. -...

Thomson Reuters ONE via COMTEX) --Multi-Electrode System Built Upon Clinical Success and Strong Safety Profile of Single-Electrode Symplicity(TM) Renal Denervation System MINNEAPOLIS -- December...

(Thomson Reuters ONE via COMTEX) --Activa® PC+S Deep Brain Stimulation System Enables Research Toward Personalized Treatment of Neurological and Psychological Diseases MINNEAPOLIS - December 5,...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - December 5, 2013 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.28 per share of the Company's common...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Dec 4, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Oppenheimer...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Nov 26, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Piper Jaffray...

Thomson Reuters ONE via COMTEX) --Presented at VEITH, Three-Year Clinical Data from Global ENGAGE Registry Supports Innovative Device's Market-Leading Position Worldwide MINNEAPOLIS -- Nov. 25,...

Thomson Reuters ONE via COMTEX) --Presented at VEITH, Acute Results from Initial Trial of New Medical Technology Show Promise for Endovascular Approach to Thoracic Aortic Aneurysms Involving Left...

MINNEAPOLIS - Nov. 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2014, which ended October 25, 2013. The Company reported worldwide...

Thomson Reuters ONE via COMTEX) --MINERVA Trial at AHA Meeting Shows Medtronic Pacemakers Reduce the Progression of Permanent AF by 61 Percent MINNEAPOLIS and DALLAS - Nov.18, 2013 - New research...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS -- Nov. 15, 2013 -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has classified the company's recently...

(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Nov. 14, 2013 - Medtronic, Inc. (NYSE: MDT) announced that a German court today ordered the discontinuation, in its entirety, of a prior court...

(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Nov. 11, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2014 on...

Thomson Reuters ONE via COMTEX) --LIA Software Proven to Detect Lead Failures More Frequently Than Impedance Alone on Riata, Durata and Endotak Leads MINNEAPOLIS - Nov. 7, 2013 - Medtronic, Inc....

Thomson Reuters ONE via COMTEX) --SYMPLICITY HTN-4 Will Potentially Expand Access for Additional Patients at Risk for Cardiovascular Complications Related to Uncontrolled Hypertension MINNEAPOLIS...

(Thomson Reuters ONE via COMTEX) --New Data Presented at TCT and Published by JAMA Affirms Excellent Safety Profile of Zotarolimus-Eluting Stents SAN FRANCISCO -- Oct. 31, 2013 -- According to...

(Thomson Reuters ONE via COMTEX) --Presented at TCT and Published by The Lancet, Results of DUTCH PEERS Negate Notion of Class Effect with Structural Stability of 'More Flexible and Highly...

Thomson Reuters ONE via COMTEX) --Longest-term data from the first randomized, controlled trial of renal denervation presented at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT)...

Thomson Reuters ONE via COMTEX) --First Rigorous Prospective Analysis of Extreme Risk Patients Presented at TCT13 SAN FRANCISCO and MINNEAPOLIS - Oct. 30, 2013 - Following the first U.S. data...

SAN FRANCISCO and MINNEAPOLIS - Oct. 29, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on...

Medtronic, Inc. (NYSE: MDT) today provided the following statement: As part of a patent opposition proceeding, the European Patent Office (EPO) today issued a preliminary opinion on the validity...

(Thomson Reuters ONE via COMTEX) --Long-Time Market Leader Introduces U.S. Cardiologists to Greater Power and Superior Deliverability of Next-Generation 'Export Advance' Aspiration Catheter...

Thomson Reuters ONE via COMTEX) --MEMPHIS, Tenn. - Oct. 21, 2013 - Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today the launch of the first procedure that allows...

Thomson Reuters ONE via COMTEX) --First Patients Successfully Treated With Novel 'CoreValve Evolut R' Transcatheter Valve MINNEAPOLIS - Oct. 22, 2013 - Medtronic, Inc. (NYSE: MDT) today announced...

Medtronic takes device security and any threat to patient safety seriously. Medtronic is actively engaged with security research firms and regularly conducts and uses independent assessments to...

(Thomson Reuters ONE via COMTEX) --Late Breaking Clinical Trial Features the First U.S. Data of Novel Self-Expanding Transcatheter Valve at Premier Interventional Cardiology Meeting Other...

MINNEAPOLIS - October 14, 2014 -- Medtronic today announced the U.S. Food and Drug Administration (FDA) approval of its CapSureFix Novus(TM) MRI SureScan® 5076 Lead for use with magnetic...

Thomson Reuters ONE via COMTEX) --Global Program Honors People Who Have Overcome Health Challenges with the Help of Medical Technology and Are Now Giving Back to Their Communities MINNEAPOLIS -...

Thomson Reuters ONE via COMTEX) --New Hemodialysis Platform Would Enable Delivery of Life-Saving Therapy From the Hospital to the Home NEW DELHI - October 9th, 2013 - Apollo Hospitals Enterprise...

Thomson Reuters ONE via COMTEX) --Panel Vote Underscores Clinical Benefits of Biventricular Pacing for Better Patient Outcomes and Improved Quality of Life MINNEAPOLIS - Oct. 8, 2013 - The U.S....

(Thomson Reuters ONE via COMTEX) --MiniMed® 530G with Enlite® Automatically Stops Insulin Delivery If Sensor Glucose Levels Fall Below a Predetermined Threshold MINNEAPOLIS - September 27, 2013...

(Thomson Reuters ONE via COMTEX) --New Indications for Self-Expanding Device Address Broad Area of Peripheral Artery Disease MINNEAPOLIS -- September 24, 2013 -- Expanding its role in the...

Thomson Reuters ONE via COMTEX) --Long-Term Clinical Trial Results Further Emphasize Safety and Added Benefits of Medtronic Proprietary Feature MINNEAPOLIS and ORLANDO - Sept. 23, 2013 -...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Sept. 12, 2013 - Medtronic, Inc. (NYSE: MDT) is one of the world's leading companies for sustainability, according to new ratings released today....

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Sep 6, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley...

Thomson Reuters ONE via COMTEX) --Final Clinical Outcomes from First and Longest-Running Renal Denervation Clinical Study Presented During European Society of Cardiology Congress and Accepted for...

Thomson Reuters ONE via COMTEX) --Medtronic Hospital Solutions Signs First Contracts with Two Leading Hospitals in Europe and Makes Equity Investment in NGC Medical MINNEAPOLIS AND TOLOCHENAZ -...

(Thomson Reuters ONE via COMTEX) --Six and 12-Month Data from Largest Real-World Patient Population Consistent with Symplicity Randomized Clinical Trial MINNEAPOLIS and AMSTERDAM - September 2,...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS and SINGAPORE, Aug. 29, 2013 - Medtronic announced today the official opening of a global Center of Excellence (CoE) for Business Model Innovation in...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - August 22, 2013 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.28 per share of the company's common...

MINNEAPOLIS - August 20, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2014, which ended July 26, 2013. The company reported worldwide...

Thomson Reuters ONE via COMTEX) --Med-Tech Leader Continues to Project Pre-Market Approval from U.S. FDA for Novel Peripheral Angioplasty Device in Second Half of 2015 MINNEAPOLIS -- Aug. 15, 2013...

(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Aug. 14, 2013 - Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual...

Thomson Reuters ONE via COMTEX) --Cardiocom's Patient Management Offerings Reduce Healthcare Costs and Improve Care MINNEAPOLIS - August 12, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Aug 12, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2014 on...

(Thomson Reuters ONE via COMTEX) --First Implant of Activa® PC+S Deep Brain Stimulation System Initiates Research That Could One Day Significantly Change How Neurological and Psychological...

Thomson Reuters ONE via COMTEX) --Innovative Design Enhancements Provide Patients Unprecedented Access to Diagnostic Care MINNEAPOLIS - August 6, 2013 - With the first U.S. implants of its new...

Thomson Reuters ONE via COMTEX) --25 Distance Runners from Around the World Who Benefit from Medical Technology to Run Medtronic Twin Cities Marathon Events this Fall MINNEAPOLIS - July 24, 2013 -...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS -- July 12, 2013 --Today a court in Mannheim Germany found that Medtronic's CoreValve® System infringes a patent owned by Edwards Lifesciences (the...

Thomson Reuters ONE via COMTEX) --MEMPHIS, Tenn. - July 11, 2013 - Medtronic, Inc. (NYSE:MDT) today announced the global market introduction of the CD HORIZON® SOLERA® Spinal System Sagittal...

Thomson Reuters ONE via COMTEX) --FDA Classifies Notifications MINNEAPOLIS - June 26, 2013 - In June 2013, Medtronic, Inc. (NYSE: MDT) initiated four medical device notifications to customers...

(Thomson Reuters ONE via COMTEX) --Study Marks Critical Milestone Toward Commercialization of a Third-Generation Artificial Pancreas System for People with Diabetes MINNEAPOLIS - June 24, 2013 -...

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et risus odio. Vivamus pellentesque, tortor a tempor semper, massa nulla placerat augue, sit amet convallis tellus orci ut massa....

(Thomson Reuters ONE via COMTEX) --ASPIRE In-Home Study Published in New England Journal of Medicine and Presented at American Diabetes Association Annual Scientific Sessions CHICAGO - June 22,...

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - June 20, 2013 - The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an 8 percent increase in its cash dividend, raising the...

Thomson Reuters ONE via COMTEX) --Shareholders Invited to Attend Annual Meeting on Aug. 22, 2013 MINNEAPOLIS - June 20, 2013 - The board of directors of Medtronic, Inc. (NYSE: MDT), today...

Thomson Reuters ONE via COMTEX) --INFUSE Bone Graft Remains Important Treatment Option MINNEAPOLIS - June 17, 2013 - Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings...

(Thomson Reuters ONE via COMTEX) --Study Presents Comprehensive Dataset of Patient Characteristics Collected on Extreme Risk TAVR Patients VANCOUVER - June 14, 2013 - Medtronic, Inc. (NYSE: MDT)...